0
Back To Top Jump Location
Sign In  | Cart
Left Shadow
Right Shadow
Images in Cardiology |

Transfemoral Pulmonary Valve Implantation for Severe Pulmonary Insufficiency After Ross Procedure

Karl Stangl, MD; Verena Stangl, MD; Michael Laule, MD
[+] Author Information

Copyright 2013, American College of Cardiology Foundation. All Rights Reserved.

J Am Coll Cardiol. 2013;61(6):e143-e143. doi:10.1016/j.jacc.2012.08.1031
Published online
Figures in this Article

A 73-year-old woman presented with intractable right heart failure (RHF) attributable to severe pulmonary insufficiency (A,Online Video 1). Six years previously, she had undergone a Ross procedure for severe aortic stenosis, with implantation of a decellularized porcine xenograft valve (Matrix P, Auto Tissue Berlin GmbH, Berlin, Germany). Because of the patient's poor general condition, the surgical risk was considered too high, and a catheter approach was performed (B–F,Online Video 2). A sizing balloon determined the diameter of the present narrowing of the distal anastomosis (18.9 mm). Simultaneously, coronary angiography excluded the possibility that the planned procedure could burden the left coronary artery (C). A 45-mm covered stent mounted on a 26-mm Z-Med II balloon (both Numed Inc., Denton, Texas) was implanted in the distal anastomosis (D). Finally, a 26-mm Edwards SAPIEN valve (Edwards Lifesciences, Irvine, California) was implanted within the stent (“valve in stent”) (E). Postprocedural angiography revealed excellent functional results (F). There were no complications during the procedure or during follow-up. During subsequent days, an impressive decline in the patient's signs of right heart failure was observed, and she was discharged 3 days after the procedure.

Our case shows that transcatheter pulmonary valve implantation can be safely performed in patients with failure of pulmonary grafts after the Ross procedure.

First Page Preview

View Large
First page PDF preview

Tables

Interactive Graphics

Video

References

Correspondence

Latest JACC CME

Continuing Medical Education through JACC is a convenient way to fulfill your CME requirements while learning important information about the latest advances in cardiovascular medicine.

April 2013- JACC CME Activity
Repeat Revascularization and Outcome

March 2013- JACC CME Activity
Extreme Lipoprotein(a) Levels and Improved Cardiovascular Risk Prediction

Feb 2013- JACC CME Activity
Results from the BARI 2D Trial

Jan 2013- JACC CME Activity
Prognosis Among Healthy Individuals Discharged With a Primary Diagnosis of Syncope

Dec 2012- JACC CME Activity
Incidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer

Nov 2012- JACC CME Activity
A Collaborative Analysis of Individual Patient Data From 10 Randomized Trials

Oct 2012- JACC CME Activity
Radiofrequency Ablation of Premature Ventricular Ectopy Improves the Efficacy of Cardiac Resynchronization Therapy in Nonresponders

Sept 2012- JACC CME Activity
Exercise and Pharmacological Treatment of Depressive Symptoms in Patients With Coronary Heart Disease

Aug 2012- JACC CME Activity
Reduction in Life-Threatening Ventricular Tachyarrhythmias in Statin-Treated Patients With Nonischemic Cardiomyopathy Enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy)

July 2012- JACC CME Activity
Relationship of Beta-Blocker Dose With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction

For previous CME quizzes, please follow this link to CardioSource Lifelong Learning and MOC.

 

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles